Clinical Trial Update: A HIV Vaccine Trial in Individuals Who Started Antiretrovirals During Primary or Chronic Infection (EHVA T02) [Phase 2]

View source ↗

Summary

Phase 2 HIV vaccine trial in individuals who started antiretrovirals during primary or chronic infection has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• HIV Infection

Snippet

Sponsor: ANRS, Emerging Infectious Diseases | Conditions: HIV-1-infection | Phase 2 | Status: COMPLETED